Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Current Assets: 2015-2024

Historic Current Assets for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $289.3 million.

  • Editas Medicine's Current Assets fell 34.76% to $176.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.9 million, marking a year-over-year decrease of 34.76%. This contributed to the annual value of $289.3 million for FY2024, which is 15.11% down from last year.
  • Editas Medicine's Current Assets amounted to $289.3 million in FY2024, which was down 15.11% from $340.8 million recorded in FY2023.
  • Editas Medicine's 5-year Current Assets high stood at $507.3 million for FY2021, and its period low was $289.3 million during FY2024.
  • For the 3-year period, Editas Medicine's Current Assets averaged around $329.0 million, with its median value being $340.8 million (2023).
  • In the last 5 years, Editas Medicine's Current Assets grew by 21.05% in 2021 and then dropped by 29.68% in 2022.
  • Over the past 5 years, Editas Medicine's Current Assets (Yearly) stood at $419.1 million in 2020, then rose by 21.05% to $507.3 million in 2021, then fell by 29.68% to $356.8 million in 2022, then dropped by 4.46% to $340.8 million in 2023, then decreased by 15.11% to $289.3 million in 2024.